Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Royston Ivor, Chairman & CEO. Officer active across 2 companies, notably Viracta Therapeutics, Inc.. Cumulatively, 15 reports have been logged. Split: 1 buy · 0 sell. Total volume traded: €39k. History available since 15 November 2021. The latest transaction was filed on 25 November 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Royston Ivor
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8,000 shares@ US$5.5687.5% of flowCommon StockSEC:0001209191-21-064540:0
Canonical exit: 13 Feb 2022 (T+90)
15 of 15 declarations
About Royston Ivor
ROYSTON IVOR is Président-Directeur Général and a director of Viracta Therapeutics, Inc. The 15 filings on record cover the period from 2021-11-15 to 2024-11-27, and the sampled recent filings show buys of EUR 38876 and no sales, with option exercise as the modal transaction nature.